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Abstract: Imagine devices or particles so small that they are invisible to the naked eye. 
Imagine that such entities could be used to patrol our bodies and autonomously augment 
endogenous defense and repair mechanisms. Imagine the defeat of illness at a fraction of the 
current costs. Bionanotechnology is the field of science that deals with just that: the 
development of imaging, tracking, targeting, sensing, diagnostic, and eventually therapeutic 
capabilities based on particles in the nanometer range, i.e., “nanoparticles”. Within the 
extensive group of nanoparticles, semiconducting quantum dots play a central and 
prominent role. Quantum dots excel at a myriad of physical properties, most notably their 
fluorescent properties, such as high quantum yield, photo-stability, broad absorption 
spectra, and their remarkable size-dependent emission-tunability.  
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1. Introduction 
From its first conception, envisioning technology beyond the microscopic level, below 
approximately 100 nm, nanotechnology has seen slow but steady development over the past five 
decades. Nanotechnological concepts and the fascinating possibilities that might arise when it would 
become possible to manipulate matter at the atomic scale were originally described in a lecture titled 
“There's plenty of room at the bottom”, delivered at an American Physical Society meeting in 1959 by 
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the physicist Richard Feynman, a Nobel Prize-laureate in 1965. The term “nanotechnology” was first 
defined by Norio Taniguchi in 1974 when he wrote that the term was derived from nanometer and 
defined “nanotechnology” as follows: “Nanotechnology mainly consists of the processing of, 
separation, consolidation, and deformation of materials by one atom or by one molecule” [1]. The 
nanoscale―one billionth of a meter (10
−9 m)―marks the hazy boundary between the classical, 
Newtonian, and quantum mechanical worlds, and thus a variety of unique and deviant physical and 
chemical properties arise in nanoparticles compared with bulk materials. 
Figure 1. An example of nanotechnological progress, i.e., a thermally driven single-
molecule nanocar capable of moving on a gold surface. (a) Structure of the nanocar 
(nanocar-1); fullerene wheels and chassis parts can rotate because of the alkyne 
connections, giving the nanocar the ability to roll on the surface and flexibility orthogonal 
to the surface plane. Synthesis and study of several related structures clarified that the 
alkyl units were critical for the solubility of the molecule. (b) Three-dimensional model 
and summary of the method of motion for nanocar-1, which consecutively pivots and then 
translates perpendicular to its axes. For clarity, the structure is drawn devoid of the alkoxy 
units. (c) High resolution scanning tunneling microscope (STM) image of nanocar-1 on an 
Au(111) surface (Vb = 0.4 V, It = 60 pA). Bright features are fullerene wheels; 
intramolecular oligo(phenylene ethynylene) and alkyl groups are not visible. Images 
courtesy of James M. Tour and reprinted with permission from [2] (© 2005 American 
Chemical Society). 
 
 
At the outset it was envisioned that nanoscopically small devices could replace conventional 
industrial production methods and since such machines may convert matter at the atomic level to the 
desired end-product, a high substrate and product specificity, energy and conversion efficiency, and 
thus very little to no waste might be expected. These goals are still being pursued with significant Int. J. Mol. Sci. 2010, 11                 
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scientific vigilance, but it is in a sense rather fitting that developments have been fastest in the 
biological and biomedical field, where substrate specificity, conversion efficiency, and product stereo-
selectivity play crucial roles and are unparalleled endogenous biological traits. That such small devices 
are by no means the vision of mad scientists or science fiction writers, but already a reality is for 
instance exemplified by the engineering of nano-cars (Figure 1): molecular chassis with fullerene 
wheels capable of motion and even directional control [2].  
In the biomedical field, nano-devices that might augment natural healing or defense processes, that 
could perform microsurgical tasks, actively and intelligently eradicate aberrant cells and tissues would 
constitute a revolution that surpasses all the milestones of the last centuries, such as the discovery in 
1840 that ether gas can be used as a general anesthetic by Crawford Long and William Morton, Louis 
Pasteur's unveiling of the artificial generation of weakened microorganisms in 1885―the principle 
was first established for the rabies vaccine―that paved the way for every other vaccine, or even the 
discovery of the first antibiotic, penicillin, by Sir Alexander Fleming in 1928. All these feats have 
saved the lives of millions of people. 
Small nanoscopic medical devices that intelligently watch over the health of the individual―the 
stuff that Sci-Fi dreams are made of, such as the 1966 movie Fantastic Voyage, where Richard 
Fleischer envisioned to send surgeons in their miniaturized submarine into the body of an escaped 
Czech scientist to remove a blood clot in his brain, or more aptly considering the scope of this 
editorial, the “nanites” that autonomously regenerate tissue in injured Borg, used in Gene 
Roddenberry’s Star Trek series―are perhaps a long way of, but it is necessary to envision such goals 
for progress’ sake. On the other hand, the first “small step” may already have preceded “the giant leap” 
in current developments in nanoparticles that combine detectability, targeting, and therapeutic options 
in a single particle, i.e., “multifunctional” or “multimodal” probes. I personally prefer the latter term. 
Whether it is justified to already call this “thera(g)nostics” or not is a matter of debate, but fact is that 
such attributes have been demonstrated in a variety of nanoparticles by a number of laboratories.  
Developments in this novel field of science at the boundary between physical, chemical, biological 
and medical science, i.e., “Bionanotechnology”, have been relatively slow at the beginning, but 
momentum is taken up and current developments are progressing exponentially, as semi-empirically 
deducible from the increase in the yearly number of publications (Figure 2). This normally is an 
indication that a new technology is maturing and this is certainly the case for a number of 
nanoparticles currently employed for research purposes. Evolutionary progress is complementary in 
the fields of nanotechnology and biotechnology, and there is a constant technological exchange and 
traffic between these. Nanoparticles are not only used to elucidate and study biological processes, but 
biomolecules, viruses, and cells are being used to fabricate and organize nano-materials that could not 
be produced via synthetic techniques alone. The impact that nanostructured materials are already 
having on biological and biomedical research is profound. One of the most exciting applications are 
imageable nanoparticles, foremost fluorescent semiconducting quantum dots (Qdots). 
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Figure 2. Overview of the number of publications on nanoparticles until 2009  from 
SCOPUS™ as a measure for the development of the bionanotechnological field over the 
past three decades  [3]. Notice that currently the number of publications released show 
exponential growth dynamics. Similar trends were obtained when using NCBI/Pubmed 
queries.  
 
2. Semiconductor Quantum Dots 
Semiconducting nanocrystal technology was initially developed in the early 1980s in the labs of 
Louis Brus at Bell Laboratories [4] and of Alexander Efros and Alexei I. Ekimov [5] of the A.F. Ioffe 
Physical-Technical Institute in St. Petersburg. The term “quantum dot” was first contrived by Mark A. 
Reed in 1988 and denotes nanocrystalline semiconducting fluorophores, whose excitons are confined 
in all three spatial dimensions―quantum confinement: strict confinement of electrons and holes when 
the nanoparticle radius is below the exciton Bohr radius―and have typical diameters of 2–20 nm. 
Generally they are binary systems composed of a core of semiconducting material enclosed within a 
shell of another semiconductor (Figure 3: Centre). Qdot fluorescence is caused by the bandgap 
between the valence and the conduction electron bands, and absorption of a photon higher in energy 
than the spectral bandgap of the core semiconductor results in electron excitation to the conduction 
band, generating an electron-hole pair (exciton). The long lifetime in the order of 10–40 ns increases 
the probability of absorption at shorter wavelengths, and produces a broad absorption spectrum   
(Figure 3A). Since the physical size of the bandgap determines the photon’s emission wavelength, it is 
possible to control the fluorescence wavelength by the size of the nanoparticle (the bandgap energy is 
inversely proportional to the square of the size of the quantum dot). Simply put: the larger the Qdot, 
the redder its emission (Figure 3A). Qdots are characterized by a number of unique physical 
properties, but since they are currently predominantly used as imaging agents it is particularly worth Int. J. Mol. Sci. 2010, 11                 
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mentioning their optical properties: strong light absorbance, size-tunable emission, bright 
fluorescence/high quantum yield, narrow symmetric emission bands, high photostability and low 
photobleaching rates, and their broad absorption spectrum allows the simultaneous excitation of Qdots 
of all sizes by a single excitation light source in the UV to violet part of the spectrum (Figure 3A). 
Chemical adaptation of the nanoparticle surface not only renders the particle water-soluble, allows 
biocompatiblilization and functionalization, but also eliminates photobleaching by physically 
excluding interaction of the excited state particle with molecular oxygen and thus prevents formation 
of reactive oxygen species, such as singlet oxygen. By attaching particular targeting molecules, Qdots 
can be directed to sub-cellular structures (Figure 3B) or even aberrant tissues in intact   
animals (Figure 3C), and therefore can be used for bio-imaging purposes in cells [6] and animals [7,8]. 
Next to bio-imaging applications, Qdots are currently being used in bio-analytical assays [9] with a 
pure research focus. Ultimately, such strategies might be used in human patients to localize and treat 
diseased tissues and organs, as depicted in figure 3D, or to replace conventional methods in clinical 
assays for diagnostic purposes. Drug delivery and therapeutic applications, such as photodynamic 
therapy [10] and gene silencing [11,12], as well as applications that combine imaging capabilities with 
delivery of a therapeutic payload are presently being developed and tested in lab-animals. Clinical 
applications and trails in humans have not yet been performed pending resolution of remaining issues, 
such as tissue targeting, renal clearance, and toxicity issues. 
3. Quo Vadis Quantum Dots 
This special edition of the International Journal of Molecular Sciences (IJMS) brings together a 
number of articles dedicated to quantum dots and their application in life and biomedical sciences. 
Collectively, these articles illustrate recent advances in the field and highlight a promising and bright 
future for life- and biomedical sciences as well as the nanotechnological sciences that created them in 
the first place. 
Maureen Walling and Jennifer Novak from Jason Shepard’s group, University at Albany (US) 
extensively review the application of quantum dots in live cell and in vivo imaging [13]. Their review 
focuses on imaging applications in single cell microscopy, tracking of individual cells, e.g., metastasis, 
and whole animal imaging and concomitant problems, as well as tackling the issue of targeting Qdots 
to particular (sub)cellular structures, cells, and tissues. 
Jana Drbohlavova, Vojtech Adam, Rene Kizek, and Jaromir Hubalek, Brno University of 
Technology (CZ), center their review on the preparation and characterization of Qdots [14]. The 
authors formulate several criteria for the safe use of Qdots in medicine and discuss short-comings in 
the current generation of Qdots.  
Gerard Giraud et al. from the University of Edinburgh (UK) in a collaborative effort between the 
Institute for Condensed Matter and Complex Systems, the Division of Pathway Medicine, the School 
of Chemistry, the Institute of Integrated Systems, and the National Physical Laboratory, describe the 
use of Qdot labeling combined with fluorescence lifetime imaging microscopy for the detection of 
DNA hybridization events on DNA microarrays [15]. The authors show in this paper that exploitation 
of the relatively long lifetime of quantum dots with a FLIM imager that combines evanescent wave Int. J. Mol. Sci. 2010, 11                 
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excitation with wide field detection and a quadrant anode mounted on an inverted microscope can be 
used to increase the contrast ratio of DNA microarrays by a factor of two. 
Figure 3. Quantum dots as multifunctional research and diagnostic tools.  Centre: 
schematic representation of a core/shell quantum dot. (a) Illustration of how the physical 
size of the quantum dot determines its fluorescent properties: the larger the Qdot, the larger 
the Stokes-shift, i.e., the redder the emission. Also note from the broad absorption spectra 
in the back that virtually all Qdots can be excited simultaneously with one wavelength in 
the violet to UV region of the electromagnetic spectrum. (b) Multiplex pseudocoloured 
image of cellular structures visualized with quantum dots. Fixed human epithelial cells 
were stained to show the nucleus (blue; 655-nm Qdots), Ki-67 cell proliferation proteins in 
the nucleus (magenta; 605-Qdots), mitochondria (orange; 525-Qdots), microtubules 
(green; 565-Qdots), and actin filaments (red; 705-Qdots). Courtesy of Quantum Dot 
Corp./Invitrogen. (c) Example of Qdot-based imaging capabilities in intact animals by 
simultaneous imaging of multicolor Qdot-encoded microbeads (0.5 µm diameter) emitting 
green, yellow or red light. Approximately 1–2 million beads in each color were injected 
subcutaneously at three adjacent locations on a host animal. Notice the significant 
brightness and spectral shifting advantages away from auto-fluorescence. Adapted with 
permission from Macmillan Publishers Ltd: Nature Biotechnology [16], (© 2004). (d) The 
ultimate goal would be to use functionalized Qdots for the simultaneous detection and 
concomitant treatment of disease states in human patients. 
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In their paper, Raquel Ibáñez-Peral et al. from the departments of Chemistry and Biomolecular 
Sciences, Earth Sciences, and Physics from Macquarie University and the School of Biotechnology 
and Biomolecular Sciences, University of New South Wales in Sydney (AU) investigate whether 
Qdots can be used as suitable multicolor optical labels of specific nucleotide probes for microbial 
identification using Flow Cytometry (FCM) [17]. Since individual Qdots fluoresce and scatter below 
the resolution of the flow cytometer, the authors conjugated Qdots to paramagnetic beads 
(Dynabeads). They conclude that the minimum fluorophore-concentration required for detection of 
Qdots above the autofluorescent background was 100-fold less than for the commonly used 
fluorophore FITC, even under suboptimal excitation conditions. Nonetheless, their research also 
showed that Qdot binding to the beads markedly influences their optical properties and this fact alone 
suggests that the application of Qdots for FCM needs further study and development. 
Takashi Jin and Yoshichika Yoshioka et al. from the WPI Immunology Frontier Research Center, 
Osaka University (JP), in an excellent paper, describe preparation and characterization of glutathione 
(GSH)-coated near-infrared (NIR) Qdots for in vivo fluorescence imaging  [18]. NIR probes are 
increasingly being used for deep tissue imaging, because they emit outside the autofluorescence 
window, and excitation beams in this region of the electromagnetic spectrum display better tissue 
penetrability and reduced photon scattering. Jin et al. developed an easy synthesis route for GSH-
coated NIR Qdots with a core-shell structure (CdSeTe/CdS) that can be used in cellular imaging, but 
also in intact animals, as demonstrated by lymph node imaging in a C57BL/6J mouse―the most 
widely used inbred strain refractory to many tumors, characterized by resistance to audiogenic 
seizures, relatively low bone density, development of age-related hearing loss, susceptibility to   
diet-induced obesity, type 2 diabetes, and atherosclerosis [19]. 
To conclude, Ming-Shu Hsieh and Nion-Heng Shiao from Wen-Hsiung Chan’ lab, Department of 
Bioscience Technology and Center for Nanotechnology, Chung Yuan Christian University (TW), 
report on the influence of CdSe-core Qdots on mouse oocyte maturation, fertilization, and subsequent 
pre- and post-implantation fetal development [20]. The authors show that exposure of mouse oocytes 
to CdSe-core Qdots during in vitro maturation decreases cell number, induces apoptosis, and inhibits 
post-implantation development. Encapsulation with a ZnS shell effectively abrogates cytotoxic and 
teratogenic effects, demonstrating not only the potential toxicity in type I Qdots, but also the influence 
of the outer shielding. 
4. Concluding Remarks 
Bionanotechnology has undeniably arrived, but it has yet to realize its full potential. Since 
developments in this adolescent field of science are irrefutably moving at exponential rates (Figure 2), 
the next decade will be extremely exciting for those of us working at the interface of nanoscience, 
chemistry, medicine, and biology. Similar quantum leaps may be anticipated as those made in the field 
of molecular biology and biotechnology around the turn of the millennium and perhaps one day small 
medical devices in our circulation will augment natural biological defense and repair systems as 
envisioned by science fiction.  
Currently, we are at a stage where a myriad of nanoparticles have been developed: Qdots that give 
away the location of cancer cells in tissues of higher organisms, nanoparticles that deliver therapeutic Int. J. Mol. Sci. 2010, 11                 
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drugs directly to target cells for in situ delivery and as such minimize damage to healthy cells, 
nanoshells that concentrate the heat from infrared light to destroy cancer cells with minimal damage to 
surrounding healthy tissue (thermal ablation), and others. The series of papers in this special edition 
highlight the rapid progress in this field and it is hoped that the next generation of nanoparticles will be 
a major asset in the fight against numerous diseases, especially cancers. However, nanoparticles 
currently employed can hardly be called “intelligent” and the coming generations of nanoparticles will 
certainly include logic decision mechanisms in order to smarten up such particles. The first steps 
toward such systems are already under way, as exemplified by the recent paper by Motornov et al., 
who coupled pH-responsive nanoparticles with enzyme-based ‘‘logic gates’’ that were able to perform 
AND/OR logic operations in which biochemical input signals were transduced into an output signal 
(pH change) sufficient to induce reversible structural changes of the nanoparticle assemblies [21]. 
Their proposed scheme enabled the processing and amplification of biochemical signals. 
As a final point, logic dictates a note of caution: the deviant behavior of nanoparticles compared 
with bulk materials not only brings about extraordinary physical and chemical properties and as such 
provides the basis for their implementation and success in biological and biomedical research, but 
concomitantly threatens the safe use of such nanomaterials in a clinical setting. There are now 
numerous studies that indicate that nanoparticles of various forms not only potentially exhibit cyto- 
and genotoxic effects [22,23], threaten fertility and fetal development [20] , but also physically disrupt 
biomembranes causing changes in fluidity, cell membrane permeability, nanoparticle adsorption onto 
or intercalation into the lipid bilayer, with possibly detrimental cellular effects [24,25]. Extensive and 
long term health and toxicity studies are rare, let alone studies that focus on environmental impact and 
particularly ecosystem effects. This might be a cause for concern, especially since nanoparticles are 
being generated in all flavors, from a myriad of raw materials, at an ever increasing speed and already 
supposedly have silently found their way into cosmetics and foodstuffs without such studies. Such 
news flashes have understandably led to considerable consternation in post-BSE Europe more so than 
anywhere else in the world. Perhaps those doing the engineering and science should more closely 
collaborate with toxicological and environmental research groups, whilst governmental agencies and 
institutions should be more aware of the potential dangers, in order to steer clear of errors made in the 
past with so many new technologies and avoid “end-of-pipe” solutions. If one thing has become clear 
regarding technological advances in the last century, mopping up is always a worse scenario than 
clever engineering from the bottom up. Nonetheless, it is my opinion that bionanotechnology and 
quantum dots in particular, have a bright future and that it will carry us far on the road of progress, 
provided we use our common sense. 
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